Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04873362 |
|---|---|
| Brief Title: | A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy (Astefania) |
| First Submitted : | April 21, 2021 |
| First Submitted that Met QC Criteria : | May 4, 2021 |
| First Posted : | May 5, 2021 |
| Last Update Submitted that Met QC Criteria : | April 17, 2024 |
| Last Update Posted : | April 18, 2024 |